Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medical Ikkou Group Co., Ltd. (3353:JPX), powered by AI.
Medical Ikkou Group Co., Ltd. is currently trading at ¥2,690. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medical Ikkou Group Co., Ltd. on Alpha Lenz.
View Medical Ikkou Group Co., Ltd.'s valuation metrics on Alpha Lenz.
“Medical Ikkou Group Co., Ltd.'s ROE is 8.3%. Explore profitability and growth together.”
Ask for details →Medical Ikkou Group Co., Ltd. operates primarily within the healthcare sector, focusing on the distribution and sale of medical and healthcare-related products. The company's primary function is to supply various medical facilities, including hospitals, clinics, and pharmacies, with a broad range of medical devices, pharmaceuticals, and other essential healthcare products. This distribution network is crucial in ensuring that healthcare providers have timely access to the products necessary for patient care and medical operations. Medical Ikkou Group is notable for its comprehensive product offerings, which encompass both high-tech medical equipment and everyday healthcare supplies. This allows the company to cater to a diverse array of healthcare providers, thereby impacting multiple facets of the healthcare industry. In the financial market, Medical Ikkou Group Co., Ltd. plays a significant role by contributing to the stability and efficiency of healthcare services in the regions it operates. Its distribution activities help enable the healthcare sector to function smoothly, illustrating the critical intersection of logistics and medical service delivery.
“Medical Ikkou Group Co., Ltd.'s ROE is 8.3%. Explore profitability and growth together.”
Ask for details →Medical Ikkou Group Co., Ltd. (ticker: 3353) is a company listed on JPX in the Industrials sector (Conglomerates). It has approximately 1,547 employees.
The current price is 2,690 with a P/E ratio of -x and P/B of -x.
ROE is 8.29% and operating margin is 3.50%. Annual revenue is $48.4B.